Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 50090-1382

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 50090-1382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical Structure (Ipratropium 01)
Chemical structure diagram of ipratropium bromide, showing its molecular components including hydroxyl groups, aromatic ring, and quaternary ammonium group complexed with sulfuric acid (H2SO4).*
FDA Label Image

Chemical Structure (Ipratropium 02)

Chemical Structure (Ipratropium 02)
Chemical structure diagram of Ipratropium Bromide illustrating the molecular arrangement, including a bicyclic ring, quaternary ammonium group, and bromide hydrate (Br- H2O) on the right side.*
FDA Label Image

Figure (Ipratropium 03)

Figure (Ipratropium 03)
A line graph depicting lung function in liters on the y-axis versus hours after dosing on the x-axis, for Albuterol, Ipratropium, and a combination of Ipratropium Bromide and Albuterol Sulfate. The graph shows changes over an 8-hour period following inhalation dosing.*
FDA Label Image

Figure 1 (Ipratropium 04)

Figure 1 (Ipratropium 04)
An instructional line drawing showing the assembly of a respiratory inhalation device. It depicts a hand holding the mouthpiece connected to a base, with a vial or container being inserted or attached to the device, indicating steps for device preparation or use.*
FDA Label Image

Figure 2 (Ipratropium 05)

Figure 2 (Ipratropium 05)
An instructional diagram showing a hand attaching a small component to a respiratory inhalation device, likely demonstrating part of the assembly or preparation process for use.*
FDA Label Image

Figures 3 And 4 (Ipratropium 06)

Figures 3 And 4 (Ipratropium 06)
Two instructional line illustrations labeled Figure 3 and Figure 4 showing the use of an inhalation device with a mouthpiece and a face mask, respectively. Each illustration depicts a person holding and using the device for respiratory inhalation of the medication solution.*
FDA Label Image

Rdp Logo (Ipratropium 07)

Rdp Logo (Ipratropium 07)
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE inhalation solution packaging label by A-S Medication Solutions. The label highlights the drug name prominently and notes it as a prescription solution for respiratory inhalation. The label is mostly white with blue and orange text and design elements.*
FDA Label Image

Label Image (Lbl500901382)

Label Image (Lbl500901382)
The image shows a drug vial label for Ipratropium Bromide and Albuterol Sulfate inhalation solution by A-S Medication Solutions. It specifies the strength as 2.5 mg and 0.5 mg per 3 mL, with a package size of 30 vials in a multi-dose unit. Storage instructions indicate to keep at 59 to 77 degrees Fahrenheit. The label includes the NDC 50090-1382-0 and lot number 6445-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.